N -salicyloyl tryptamine derivative exerts antiatherosclerotic effects by ameliorating endothelial inflammation and apoptosis
Journal of Pharmacy and Pharmacology · 2026
DOI: 10.1093/jpp/rgaf116 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2026. Verfasst von Liuli Cao und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Science, Hengyang Medical School, University of South China, No. 28, Changsheng West Road, Zhengxiang District, Hengyang, Hu…. Hauptthemen laut MEDLINE: Tryptamines, Atherosclerosis, Apoptosis, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Natural Sciences Foundation of Hunan Province, Scientific Research Project of Hunan Provincial Department of Education, Project of Hunan Provincial Health Committee.
Abstract (Originalsprache)
Objectives
Atherosclerosis (AS) is a chronic inflammatory disease driven by lipids that poses a serious threat to human health. Therefore, the development of drugs with both anti-inflammatory and lipid-lowering properties can provide new hope for the treatment of AS.
Methods
Previous studies have shown that the N-salicyloyl tryptamine derivative B2, formed by combining salicylic acid derivatives and the melatonin skeleton, exhibits strong anti-inflammatory activity and high biosafety. In this study, we used lipopolysaccharide (LPS)/ adenosine triphosphate (ATP) or LPS-stimulated macrophage-conditioned medium to establish an endothelial cell inflammation model. Apolipoprotein E−/− (ApoE−/−) mice fed a high-fat diet (HFD) were used to establish the atherosclerosis animal model. Key findings We found that B2 inhibited LPS/ATP-induced inflammation and apoptosis of endothelial cells, reduced monocyte–endothelial cell adhesion, decreased vascular cell adhesion molecule-1, intercellular adhesion molecule-1, monocyte chemoattractant protein-1, interleukin-6 (IL-6), and interleukin-1β, and inhibited the mitogen-activated protein kinase kinase 4/c-Jun N-terminal kinase pathway. In ApoE−/− mice fed a HFD, ELISA and lipid assay revealed that B2 reduced plasma IL-6 and triglyceride levels. Meanwhile, Oil Red O staining and Masson staining showed that B2 decreased the aortic plaque area and the degree of fibrosis.
Conclusions
These findings suggested that B2 exerts both anti-inflammatory and lipid-lowering effects, providing a new intervention approach and direction for the prevention and treatment of AS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Science, Hengyang Medical School, University of South China, No. 28, Changsheng West Road, Zhengxiang District, Hengyang, Hunan 421001, China.
- The First Affiliated Hospital, Hengyang Medical School, University of South China, No. 69, Chuanshan Road, Shigu District, Hengyang, Hunan 421001, China.
- National Health Commission Key Laboratory of Birth Defect Research and Prevention, Hunan Provincial Maternal and Child Health Care Hospital, No. 53, Xiangchun Road, Kaifu District, Changsha, Hunan 410008, China.
ORCID-Profile: Shu-Zhi Wang
Förderung
- Natural Sciences Foundation of Hunan Province
- Scientific Research Project of Hunan Provincial Department of Education
- Project of Hunan Provincial Health Committee
- University of South China, China
Zitieren
APA
Cao, L., Ding, Y., Li, L., Wang, Z., & Wang, S. Z. (2026). N -salicyloyl tryptamine derivative exerts antiatherosclerotic effects by ameliorating endothelial inflammation and apoptosis. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf116
Vancouver
Cao L, Ding Y, Li L, Wang Z, Wang SZ. N -salicyloyl tryptamine derivative exerts antiatherosclerotic effects by ameliorating endothelial inflammation and apoptosis. Journal of Pharmacy and Pharmacology. 2026. doi:10.1093/jpp/rgaf116
BibTeX
@article{Cao2026,
author = {Cao, Liuli and Ding, Yang and Li, Lixia and Wang, Zhen and Wang, Shu-Zhi},
title = {N -salicyloyl tryptamine derivative exerts antiatherosclerotic effects by ameliorating endothelial inflammation and apoptosis},
journal = {Journal of Pharmacy and Pharmacology},
year = {2026},
doi = {10.1093/jpp/rgaf116}
}
EUVIMED